浩宇生醫 (6872)
浩宇生醫 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$0.81M, up 22.6% from a year earlier. EPS over the last four quarters totals -NT$2.12.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2025-03-07
- Founded
- 2015-03-12
- Paid-in capital
- NT$707.51M
- Common shares issued
- 70,750,511
- Legal name
- 浩宇生醫股份有限公司
- Website
- https://navifus.com/
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$0.81M | -4.3% | +22.6% |
| 2026-08 | NT$0.85M | +7.2% | -65.3% |
Year to date: +183.3% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -0.61 |
| 2026 Q1 | -0.41 |
| 2025 Q4 | -0.60 |
| 2025 Q3 | -0.50 |
| 2025 Q2 | -0.56 |
| 2025 Q1 | -0.48 |
| 2024 Q4 | -0.25 |
| 2024 Q3 | -0.51 |
Last four quarters: -NT$2.12
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 373 | 0.1% |
| 1,000–5,000 shares | 1,630 | 4.8% |
| 5,001–10,000 shares | 313 | 3.5% |
| 10,001–15,000 shares | 106 | 1.9% |
| 15,001–20,000 shares | 91 | 2.4% |
| 20,001–30,000 shares | 114 | 4.1% |
| 30,001–40,000 shares | 41 | 2.0% |
| 40,001–50,000 shares | 33 | 2.1% |
| 50,001–100,000 shares | 73 | 7.3% |
| 100,001–200,000 shares | 36 | 6.9% |
| 200,001–400,000 shares | 18 | 7.3% |
| 400,001–600,000 shares | 9 | 6.1% |
| 600,001–800,000 shares | 5 | 4.8% |
| 800,001–1,000,000 shares | 3 | 3.8% |
| 1,000,001+ shares | 11 | 42.7% |
TDCC data for 2026-10-16: 11 holders own more than 1,000 lots (42.7% of shares), and 373 hold less than one lot (0.1%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -3 | 0 | 0 | -3 |
| 2026-10-16 | 3 | 0 | 0 | 3 |
| 2026-10-15 | -1 | 0 | 0 | -1 |
| 2026-10-14 | -9 | 0 | 0 | -9 |
| 2026-10-13 | -5 | 0 | 0 | -5 |
| 2026-10-12 | 12 | 0 | 0 | 12 |
| 2026-10-08 | -2 | 0 | 0 | -2 |
| 2026-10-07 | -5 | 0 | 0 | -5 |
| 2026-10-06 | 2 | 0 | -1 | 1 |
| 2026-10-05 | 1 | 0 | 0 | 1 |
| 2026-10-02 | -13 | 0 | 0 | -13 |
| 2026-10-01 | 3 | 0 | 0 | 3 |
| 2026-09-30 | -26 | 0 | 0 | -26 |
| 2026-09-29 | 21 | 0 | 0 | 21 |
| 2026-09-24 | 2 | 0 | 0 | 2 |
| 2026-09-23 | -29 | 0 | 0 | -29 |
| 2026-09-22 | -114 | 0 | -4 | -118 |
| 2026-09-21 | 179 | 0 | 4 | 183 |
| 2026-09-18 | -5 | 0 | 0 | -5 |
| 2026-09-17 | -6 | 0 | 0 | -6 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 4 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$19.85 (2026-10-19); 52-week range NT$13.80–27.05.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.